In the news | 4th October 2023
Data integrity is priceless in this era of a digital gold rush
In this PharmTech article, Nathalie Batoux and Dan Rayner, Product Managers at IDBS, discuss data integrity in the pharmaceutical industry and how it’s priceless in today’s digital gold rush. They explain how searchable, widely compatible and reusable data, when coupled with artificial intelligence and machine learning, can improve product and process efficiency, augment decision-making and accelerate drug discovery.
CMC regulatory submissions: Why knowledge continuity matters
Biopharma organizations have invested heavily in managing CMC data, yet many continue to face a less visible challenge: preserving the knowledge behind critical development decisions. As products progress through development and teams evolve, maintaining scientific context can become just as important as maintaining the underlying data.
i3 2027 registration
IDBS i3 2027 brings together life sciences leaders to explore how connected data, AI, and modern informatics are transforming scientific innovation. Join us in Woking for 1.5 days of customer stories, expert insights, interactive sessions, and networking opportunities.
Six reasons to transition from on‑premise to a cloud‑based laboratory data management system
We dig deep into some of the compelling reasons to move from on-premise to a cloud-based laboratory data management system.
Why CMC continuity is the missing link between development and manufacturing
Discover why CMC continuity is the missing link between development and manufacturing, and how preserving connected product and process knowledge helps reduce handoff risk, accelerate tech transfer, and strengthen manufacturing readiness.
